Launched in April 2022, Cellistic specializes in process development and manufacture of cell therapies based on human induced pluripotent stem cell (iPSC) technology. The company’s focus and expertise in iPSC generation and differentiation protocol development makes it well-positioned to partner with innovative cell therapy developers to establish novel advanced therapies. With more than a decade of scientific and technical knowledge transfer from sister company Ncardia, Cellistic is uniquely experienced in designing and optimizing manufacturing procedures for iPSCs that deliver quality products at scale.
For more information, visit www.cellistic.com.
Company Details
- Employees
- 89
- Address
- Rue Edouard Belin 2, Mont-Saint-Guibert,1435,belgium
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.cellistic.com/
- Keywords
- Technician jobs.
- HQ
- Mont-Saint-Guibert
Cellistic Questions
Cellistic's website is https://www.cellistic.com/
Cellistic's LinkedIn profile is https://be.linkedin.com/company/cellistic
Cellistic has
89 employees.
View email and phone details for 89
employees at Cellistic.
Cellistic's industry is
Biotechnology Research
Cellistic's top competitors are
Celyad Oncology,
Univercells,
Exothera,
Mimetas,
Iteos Therapeutics,
Tissuse Gmbh,
Ncardia,
Ucb,
Novadip Biosciences S.a.,
Cellaïon.
Cellistic's categories are Biotechnology Research
